cathelicidinSARS-CoV-2

Tanay Bhatt1, Binita Dam1,2, Sneha Uday Khedkar1

  • 1IFOM-inStem Joint Research Laboratory, Centre for Inflammation and Tissue Homeostasis, Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, Karnataka, India.

Frontiers in immunology
|November 29, 2023
PubMed
概括

人类cathelicidin (LL37),一种抗微生物,通过破坏病毒膜,有效地中和SARS-CoV-2变种. 它的抗病毒活性由尼胺胺增强,提供了对疫苗逃脱的潜在策略.